A pill that doubles life expectancy in patients with pancreatic cancer has been hailed as the biggest breakthrough for ...

Farber's Brian Wolpin, MD, MPH, will present positive results from the RASolute 302 trial showing a substantial prolongation of survival for patients with previously treated metastatic pancreatic ...

New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

Virta’s nutritional intervention shown to improve survival outcomes in randomized, controlled Phase II clinical trial on patients with one of the deadliest cancers Virta Health, the leader in ...

A glimmer of hope may be on the horizon for a ruthless cancer that former Sen. Ben Sasse (R-Neb.) once called a “definite death sentence.” An experimental treatment from Revolution Medicines helped ...

HER2-directed therapies, including monoclonal antibodies, ADCs, and TKIs, have improved survival in HER2-positive breast cancer patients. Clinical trials like CLEOPATRA, DESTINY-Breast01, and ...

The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with ...

ARPI-based doublet regimens improve progression-free survival broadly, yet agent choice and magnitude of benefit can vary with age and comorbidity profiles, including heightened cardiovascular and ...

Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, ...